P. Knochel et al.
was purified by means of column chromatography (pentane/diethyl ether
5:1) to give 15d as a colorless oil (303 mg, 72%). 1H NMR (300 MHz,
CDCl3): d=8.39 (d, J=5.1 Hz, 1H), 7.17 (d, J=5.1 Hz, 1H), 4.88 (m,
1H), 4.74 (m, 1H), 3.40 (d, J=0.6 Hz, 2H), 1.66 ppm (t, J=1.2 Hz, 3H);
13C NMR (75 MHz, CDCl3): d=172.07, 158.94, 152.93, 140.92, 119.21,
114.82, 46.05, 22.24 ppm; IR (ATR): n˜ =3080, 2974, 2938, 1652, 1566,
1530, 1427, 1334, 1205, 1164, 1095, 1021, 985, 894, 852, 817, 771, 732, 717,
692 cmÀ1; MS (70 eV, EI): m/z (%): 214 (15), 213 (100), 212 (17) [M]+,
211 (100), 200 (14), 199 (100), 198 (28), 197 (100), 196 (13), 174 (46), 172
(48), 132 (13), 131 (12), 118 (16), 106 (15), 92 (37), 65 (11); HRMS (EI):
m/z calcd for C8H9N2Br: 211.9949; found: 211.9915.
1398, 1366, 1290, 1275, 1243, 1181, 1122, 1107, 1072, 1024, 954, 913, 878,
850, 767, 748, 714, 696 cmÀ1; MS (70 eV, EI): m/z (%): 357 (31), 355 (33)
[M]+, 312 (33), 310 (35), 284 (22), 282 (22), 277 (21), 276 (100), 248 (36),
204 (13), 203 (48), 202 (33), 201 (12), 176 (13), 101 (20), 75 (13); HRMS
(EI): m/z calcd for C18H14O2NBr: 355.0208; found: 355.0200.
Synthesis of 3-bromo-2-(2-methylallyl)quinoline (16b): By following
TP 2, the metalation of 3-bromoquinoline (11; 416 mg, 2 mmol) was com-
pleted within 0.5 h at 258C. The reaction mixture was cooled to À408C,
then CuCN·2LiCl (1m in THF, 2.2 mL, 2.2 mmol) and 3-bromo-2-methyl-
propene (406 mg, 3.0 mmol) were added. The mixture was allowed to
warm to 258C and was stirred overnight. The reaction mixture was
quenched with saturated aqueous NH4Cl solution (10 mL), extracted
with diethyl ether (3ꢄ20 mL), and dried over anhydrous MgSO4. After
filtration, the solvent was evaporated under vacuum. The crude product
was purified by means of column chromatography (pentane/diethyl ether
10:1) to give 16b as a colorless oil (366 mg, 70%). 1H NMR (300 MHz,
CDCl3): d=8.36 (s, 1H), 8.09 (d, J=9.0 Hz, 1H), 7.75–7.70 (m, 2H),
7.57–7.52 (m, 1H), 4.92–4.91 (m, 1H), 4.56–4.54 (m, 1H), 3.90 (s, 2H),
1.90 ppm (s, 3H); 13C NMR (75 MHz, CDCl3): d=158.12, 146.47, 142.45,
139.09, 129.70, 129.07, 128.05, 126.93, 126.44, 119.03, 112.52, 46.10,
23.15 ppm; IR (ATR): n˜ =3078, 3059, 2970, 2913, 1650, 1586, 1486, 1442,
1424, 1401, 1373, 1306, 1221, 1195, 1140, 1125, 984, 887, 858, 802, 780,
745, 679 cmÀ1; MS (70 eV, EI): m/z (%): 263 (25), 262 (80), 261 (25) [M]+,
260 (79), 249 (14), 248 (96), 247 (33), 246 (100), 245 (19), 223 (30), 221
(34), 182 (11), 181 (14), 180 (29), 167 (55), 166 (17), 142 (10), 141 (13),
140 (38), 139 (10), 127 (14), 115 (29), 114 (14), 113 (11), 101 (11), 91 (10),
90 (10), 89 (12), 84 (10), 75 (16), 63 (12), 51 (10); HRMS (EI): m/z calcd
for C13H12NBr: 261.0153; found: 261.0156.
Synthesis of 5-bromo-4-cyclohex-2-enylpyrimidine (15e): By following
TP 2, the metalation of 5-bromopyrimidine (10b, 318 mg, 2 mmol) was
completed within 0.5 h at 258C. The reaction mixture was cooled to
À408C, then CuCN·2LiCl (1m in THF, 2.2 mL, 2.2 mmol) and 3-bromo-
cyclohexene (484 mg, 3.0 mmol) were added. The mixture was allowed to
warm to 258C and was stirred overnight. The reaction mixture was
quenched with saturated aqueous NH4Cl solution (10 mL), extracted
with diethyl ether (3ꢄ20 mL), and dried over anhydrous MgSO4. After
filtration, the solvent was evaporated under vacuum. The crude product
was purified by means of column chromatography (pentane/diethyl ether
8:1) to give 15e as a colorless oil (333 mg, 70%). 1H NMR (300 MHz,
CDCl3): d=9.04 (s, 1H), 8.71 (s, 1H), 6.02–5.97 (m, 1H), 5.71–5.66 (m,
1H), 4.02–3.96 (m, 1H), 2.15–2.04 (m, 3H), 1.90–1.85 (m, 1H), 1.72–
1.62 ppm (m, 2H); 13C NMR (75 MHz, CDCl3): d=171.14, 158.59,
157.06, 129.61, 126.24, 121.05, 41.88, 28.00, 24.60, 21.34 ppm; IR (ATR):
n˜ =3027, 2932, 1557, 1516, 1436, 1387, 1272, 1154, 1015, 891, 770, 720,
676, 658, 614, 569 cmÀ1; MS (70 eV, EI): m/z (%): 240 (27), 239 (26), 238
(28) [M]+, 237 (25), 225 (15), 223 (15), 212 (27), 211 (100), 210 (28), 209
(100), 199 (11), 198 (11), 197 (12), 196 (10), 174 (32), 172 (32), 159 (23),
131 (13), 130 (11), 118 (10), 79 (11), 77 (13), 51 (10); HRMS (EI): m/z
calcd for C10H11N2Br: 238.0106; found: 238.0105.
Synthesis of 5-chlorobiphenyl-2,4’-dicarboxylic acid diethyl ester (17a):
By following TP 2, the metalation of ethyl 4-chlorobenzoate (12a;
369 mg, 2.0 mmol) was completed within 12 h at 258C. A solution of
AHCTUNGRTEG[NNUN PdAHCUTNRTGEG(NNUN dba)2] (30 mg) and PACHTNUGERTN(NUGN o-furyl)3 (25 mg) in THF (2 mL) was added,
Synthesis of 5-bromo-4-(2-methylallyl)pyrimidine (15 f): By following
TP 2, the metalation of 5-bromopyrimidine (10b; 318 mg, 2 mmol) was
completed within 0.5 h at 258C. The reaction mixture was cooled to
À408C, then CuCN·2LiCl (1m in THF, 2.2 mL, 2.2 mmol) and 3-bromo-
2-methylpropene (406 mg, 3.0 mmol) were added. The mixture was al-
lowed to warm to 258C and was stirred overnight. The reaction mixture
was quenched with saturated aqueous NH4Cl solution (10 mL), extracted
with diethyl ether (3ꢄ20 mL), and dried over anhydrous MgSO4. After
filtration, the solvent was evaporated under vacuum. The crude product
was purified by means of column chromatography (pentane/diethyl ether
4:1) to give 15 f as a colorless oil (279 mg, 66%). 1H NMR (300 MHz,
CDCl3): d=9.06 (s, 1H), 8.77 (s, 1H), 4.95 (m, 1H), 4.70 (m, 1H), 3.66
(s, 2H), 1.82 ppm (s, 3H); 13C NMR (75 MHz, CDCl3): d=166.54, 158.72,
158.71, 156.79, 156.78, 140.56, 121.84, 113.97, 44.97, 22.70 ppm; IR
(ATR): n˜ =2973, 2916, 1650, 1556, 1522, 1439, 1386, 1276, 1142, 1022,
892, 758, 720 cmÀ1; MS (70 eV, EI): m/z (%): 214 (10), 213 (79), 212 (10)
[M]+, 211 (78), 199 (99), 198 (19), 197 (100), 196 (11), 174 (41), 172 (43),
133 (11), 132 (20), 131 (19), 118 (28), 117 (10), 106 (10), 104 (11), 77 (14),
52 (15), 51 (22); HRMS (EI): m/z calcd for C8H10N2Br: 211.9949; found:
211.9855.
followed by ethyl 4-iodobenzoate (828 mg, 3.0 mmol), and the reaction
mixture was stirred at 258C overnight. The reaction mixture was
quenched with saturated aqueous NH4Cl solution (10 mL), extracted
with diethyl ether (3ꢄ20 mL), and dried over anhydrous MgSO4. After
filtration, the solvent was evaporated under vacuum. The crude product
was purified by means of column chromatography (pentane/diethyl ether
6:1) to give 17a as a pale yellow oil (598 mg, 90%). 1H NMR (300 MHz,
CDCl3): d=8.12–8.09 (m, 2H), 7.87 (d, J=8.4 Hz, 1H), 7.46–7.36 (m,
4H), 4.43 (q, J=7.2 Hz, 2H), 4.11 (q, J=7.2 Hz, 2H), 1.44 (t, J=7.2 Hz,
3H), 1.04 ppm (t, J=7.2 Hz, 3H); 13C NMR (75 MHz, CDCl3): d=
167.15, 166.32, 144.92, 143.48, 137.48, 131.62, 130.52, 129.70, 129.32,
129.22, 128.32, 127.90, 61.23, 61.06, 14.35, 13.71 ppm; IR (ATR): n˜ =3069,
2980, 2904, 1710, 1610, 1591, 1556, 1465, 1386, 1365, 1266, 1241, 1177,
1099, 1032, 1015, 858, 770, 670 cmÀ1; MS (70 eV, EI): m/z (%): 334 (22),
333 (14), 332 (63) [M]+, 289 (35), 288 (19), 287 (100), 276 (12), 261 (13),
260 (13), 259 (36), 217 (16), 215 (48), 186 (11), 152 (28), 151 (21), 150
(19); HRMS (EI): m/z calcd for C18H17O4Cl: 332.0815; found: 332.0823.
Synthesis of 4-chloro-2-(2-methylallyl)benzoic acid ethyl ester (17b): By
following TP 2, the metalation of ethyl 4-chlorobenzoate (10a; 369 mg,
2.0 mmol) was completed within 12 h at 258C. The reaction mixture was
cooled to À408C, then CuCN·2LiCl (1m in THF, 2.2 mL, 2.2 mmol) and
3-bromo-2-methylpropene (406 mg, 3.0 mmol) were added. The mixture
was allowed to warm to 258C and was stirred overnight. The reaction
mixture was quenched with saturated aqueous NH4Cl solution (10 mL),
extracted with diethyl ether (3ꢄ20 mL), and dried over anhydrous
MgSO4. After filtration, the solvent was evaporated under vacuum. The
crude product was purified by means of column chromatography (pen-
tane/diethyl ether 160:1) to give 17b as a colorless oil (365 mg, 76%).
1H NMR (300 MHz, CDCl3): d=7.85–7.82 (m, 1H), 7.29–7.25 (m, 1H),
4.84–4.83 (m, 1H), 4.51–4.50 (m, 1H), 4.35 (q, J=7.2 Hz, 2H), 3.71 (s,
2H), 1.76 (s, 3H), 1.39 ppm (t, J=7.2 Hz, 3H); 13C NMR (75 MHz,
CDCl3): d=166.87, 144.54, 143.02, 137.76, 131.92, 131.16, 129.03, 126.39,
112.08, 61.02, 41.46, 22.77, 14.23 ppm; IR (ATR): n˜ =3080, 2981, 2937,
2907, 1719, 1592, 1566, 1478, 1446, 1366, 1252, 1128, 1102, 1074, 1020,
887, 868, 836, 772, 692 cmÀ1; MS (70 eV, EI): m/z (%): 240 (16), 238 (46)
[M]+, 225 (22), 223 (66), 197 (25), 196 (12), 195 (100), 194 (23), 193 (79),
Synthesis of 4-(3-bromoquinolin-2-yl)benzoic acid ethyl ester (16a): By
following TP 2, the metalation of 3-bromoquinoline (11; 416 mg,
2.0 mmol) was completed within 0.5 h at 258C. A solution of [Pd
ACHTUNGERTN(NUNG dba)2]
(30 mg) and P(o-furyl)3 (25 mg) in THF (2 mL) was added, followed by
ACHTUNGTRENNUNG
ethyl 4-iodobenzoate (828 mg, 3.0 mmol), and the reaction mixture was
stirred at 258C for 12 h. The reaction mixture was quenched with saturat-
ed aqueous NH4Cl solution (10 mL), extracted with diethyl ether (3ꢄ
20 mL), and dried over anhydrous MgSO4. After filtration, the solvent
was evaporated under vacuum. The crude product was purified by means
of column chromatography (pentane/diethyl ether 5:1) to give 16a as a
colorless solid (582 mg, 82%). M.p. 132.2–133.38C; 1H NMR (300 MHz,
CDCl3): d=8.54 (s, 1H), 8.22–8.14 (m, 3H), 7.86–7.76 (m, 4H), 7.65–7.60
(m, 1H), 4.45 (q, J=7.2 Hz, 2H), 1.45 ppm (t, J=7.2 Hz, 3H); 13C NMR
(75 MHz, CDCl3): d=166.31, 157.18, 146.54, 144.03, 140.14, 130.72,
130.31, 129.58, 129.56, 129.29, 128.39, 127.82, 126.52, 116.45, 61.12,
14.36 ppm; IR (ATR): n˜ =3066, 2974, 1713, 1612, 1571, 1546, 1484, 1476,
464
ꢃ 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2009, 15, 457 – 468